![Lisa M Campbell Regulatory Analyst Bergeson Campbell law firm](/sites/default/files/styles/author_profile/public/2023-12/12_29_23%20Carla%20Hutton.jpg?h=506c123e&itok=Utzt7Gy1)
Since 1996, Carla Hutton has monitored, researched, and written about regulatory and legislative issues that may potentially affect Bergeson & Campbell, P.C. (B&C®) clients. She is responsible for creating a number of monthly and quarterly regulatory updates for B&C's clients, as well as other documents, such as chemical-specific global assessments of regulatory developments and trends. She authors memoranda for B&C clients on regulatory and legislative developments, providing information that is focused, timely and applicable to client initiatives. These tasks have proven invaluable to many clients, keeping them aware and abreast of developing issues so that they can respond in kind and prepare for the future of their business.
Ms. Hutton brings a wealth of experience and judgment to her work in federal, state, and international chemical regulatory and legislative issues, including green chemistry, nanotechnology, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the Toxic Substances Control Act (TSCA), Proposition 65, and the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) program.
Carla Hutton's strengths include the ability to provide quickly and efficiently timely, relevant, and accurate information on specific issues for clients. Through daily monitoring of regulatory news, EPA information and other resources, she stays on top of government agency and legislative developments as they occur and quickly prepares notifications on various issues. Ms. Hutton has authored several assessments for client-specific materials. Prepared under tight deadlines, these documents still provide detailed analysis of state, federal, and international regulatory trends and developments.
Representative Engagements:
- Writes a metal-specific quarterly regulatory update for an international association of producers, users, and traders.
- Prepares and writes a quarterly update focused on chemical management regulations in Asia for metals industry associations.
- Authors items for the Nano and Other Emerging Chemical Technologies Blog, which reports on federal, local, and international regulatory, legal, and policy developments and is utilized by clients in nanotechnologies and other chemical technologies.
- Prepares a chemical-specific global assessment of regulatory developments and trends, analyzing the triggers initiating the regulatory initiatives, including scientific developments and regulatory actions undertaken in response by environmental activists, public health activists, and related stakeholders, as well as other complicating factors.
More Legal and Business Bylines From Carla N. Hutton
- EPA Extends Comment Period for Draft Scope Document for Part Two of Asbestos Risk Evaluation - (Posted On Thursday, February 10, 2022)
- EPA Seeks Comment on Proposed Renewal of ICR for TSCA Section 8(e) and FYI Notices - (Posted On Wednesday, February 09, 2022)
- OECD Publishes Report on Important Issues on Risk Assessment of Manufactured Nanomaterials - (Posted On Tuesday, February 08, 2022)
- Registration Opens for SACC Meeting on Draft Screening Level Approach for Fenceline Communities; EPA Extends Comment Period - (Posted On Tuesday, February 08, 2022)
- EPA Resumes Publishing TSCA Section 8(e) Notices to ChemView - (Posted On Saturday, February 05, 2022)
- EPA Seeks Participants for SBAR Panel on TSCA Reporting and Recordkeeping Rule for PFAS - (Posted On Thursday, February 03, 2022)
- ECHA Publishes Update to the Appendix for Nanoforms - (Posted On Wednesday, February 02, 2022)
- OMB Reviewing Proposed Rule on Procedures for Submitting Information Subject to CBI Claims under TSCA - (Posted On Monday, January 31, 2022)
- EC Committee Statement on Emerging Health and Environmental Issues Includes Nanotechnology Organics and Conversion of Micro to Nano Plastics in the Environment - (Posted On Friday, January 28, 2022)
- OECD Tour de Table Includes Update on Nano Developments in the United States - (Posted On Thursday, January 27, 2022)
The National Law Review recognizes Carla N. Hutton a Regulatory Analyst at Bergeson and Campbell as a Go-To Thought Leader for her consistent coverage of EPA rulemaking and stakeholder commentary opportunities, developments involving the (NNI) U.S. National Nanotechnology Initiative and regulatory changes concerning the European Commission (EC) Scientific Committee on Consumer Safety (SCCS). For more than two decades, Ms. Hutton has monitored, researched, and analyzed federal, state, and international chemical regulatory and legislative issues and her depth of knowledge provides NLR readers with updates that are focused, timely and digestible for a business audience. Ms. Hutton along with other professionals at Bergeson & Campbell provide updates several times a week on a wide range of matters involving the Toxic Substances Control Act (TSCA), nanotechnology, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and newly introduced legislation on low carbon fuel production.
Bergeson & Campbell is a Go-To Thought Leader for 2021 for its reporting on the Toxic Substances Control Act (TSCA) and Per- and Polyfluoroalkyl Substances (PFAS). Readers turn to the firm’s expert insights on the EPA's regulation and new rulemaking. Managing Partner Lynn L. Bergeson and Regulatory Analyst Carla N. Hutton alongside other professionals from Bergeson & Campbell provide readers with essential guidance they need to comply with these ever-changing government regulations.
The National Law Review names Bergeson & Campbell a Go-To Thought Leader in the field of Biotech, Food, and Drug law. Authors Lynn L. Bergeson and Carla N. Hutton covered extensively the White House’s new biotechnology initiative in their September 2022 article, “President Biden Launches National Biotechnology and Biomanufacturing Initiative.” The coverage reached thousands of legal and industry leaders and remains a valuable resource on the federal government’s new biotechnology focus.